5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 25.20▲ | 25.56▼ |
MA10 | N/A | N/A | N/A | 25.36▼ | 25.55▼ |
MA20 | N/A | N/A | N/A | 25.59▼ | 24.88▲ |
MA50 | N/A | N/A | N/A | 25.59▼ | N/A |
MA100 | N/A | N/A | N/A | 24.85▲ | N/A |
MA200 | N/A | N/A | N/A | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | -0.078▼ | N/A |
RSI | N/A | N/A | N/A | 43.916▼ | 48.654▼ |
STOCH | N/A | N/A | N/A | 14.417▼ | 58.084 |
WILL %R | N/A | N/A | N/A | -81.783▼ | -72.117 |
CCI | N/A | N/A | N/A | -58.618 | -104.949▼ |
MA | $TXUG Price Crossed Above MA(7) | Set Alert |
Friday, August 08, 2025 05:24 AM
Biotech company 10x Genomics (NASDAQ:TXG) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 12.9% year on year to $172.9 million. On the other hand, next quarter’s revenue guidance ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/08/25 | 25.19 | 25.235 | 25.19 | 25.235 | 100 |
07/08/25 | 25.25 | 25.3076 | 25.25 | 25.3076 | 100 |
06/08/25 | 25.00 | 25.0154 | 25.00 | 25.0154 | 101 |
05/08/25 | 25.13 | 25.13 | 25.1256 | 25.1256 | 103 |
04/08/25 | 25.3157 | 25.3157 | 25.3157 | 25.3157 | 0 |
01/08/25 | 25.00 | 25.0286 | 25.00 | 25.0286 | 111 |
31/07/25 | 25.3603 | 25.3603 | 25.1755 | 25.1755 | 1,350 |
30/07/25 | 25.5569 | 25.5569 | 25.5569 | 25.5569 | 0 |
29/07/25 | 26.11 | 26.11 | 25.795 | 25.795 | 7,010 |
28/07/25 | 25.9949 | 25.9949 | 25.9949 | 25.9949 | 66 |
|
|
||||
|
|
||||
|
|